Stay updated on DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.
Latest updates to the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations now lists Georgia as a study site. The page revision is updated to v3.3.3 and the Georgia Locations entry along with the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content, eligibility criteria, or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check56 days agoChange DetectedRemoved the government funding lapse notice from the page; this deletion does not affect the study details, eligibility criteria, or how a user interacts with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check70 days agoChange DetectedNothing substantive changed on the study details page; the sections on overview, eligibility criteria, and study plan remain the same.SummaryDifference0.4%
- Check99 days agoChange DetectedCore content now includes an important government-operating-status notice and the site version is updated to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%
- Check106 days agoChange DetectedRemoved a specific resource (Plasma cell myeloma) and added a new version identifier (v3.1.0) while preserving the previous version tag (v3.0.2).SummaryDifference0.3%
Stay in the know with updates to DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.